Business Description
Arcadia Biosciences Inc
NAICS : 311999
SIC : 2099
ISIN : US0390142042
Description
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 11.56 | |||||
Equity-to-Asset | 0.65 | |||||
Debt-to-Equity | 0.08 | |||||
Debt-to-EBITDA | -0.07 | |||||
Interest Coverage | N/A | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | -20.39 | |||||
Beneish M-Score | -1.67 | |||||
WACC vs ROIC |
Growth Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -48.9 | |||||
3-Year EBITDA Growth Rate | 20.5 | |||||
3-Year EPS without NRI Growth Rate | 47.8 | |||||
3-Year FCF Growth Rate | 54.4 | |||||
3-Year Book Growth Rate | -50.5 |
Momentum Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 38.81 | |||||
9-Day RSI | 42.18 | |||||
14-Day RSI | 42.08 | |||||
6-1 Month Momentum % | -39.49 | |||||
12-1 Month Momentum % | -66.37 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 4.17 | |||||
Quick Ratio | 3.63 | |||||
Cash Ratio | 3.24 | |||||
Days Inventory | 258.93 | |||||
Days Sales Outstanding | 46.29 | |||||
Days Payable | 201.49 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -56.4 | |||||
Shareholder Yield % | -184.39 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 36.84 | |||||
Operating Margin % | -253.72 | |||||
Net Margin % | -246.8 | |||||
FCF Margin % | -269.39 | |||||
ROE % | -83.12 | |||||
ROA % | -54.06 | |||||
ROIC % | -272.02 | |||||
ROC (Joel Greenblatt) % | -453.32 | |||||
ROCE % | -65.67 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 0.42 | |||||
PB Ratio | 0.2 | |||||
Price-to-Tangible-Book | 0.2 | |||||
EV-to-EBIT | 0.55 | |||||
EV-to-EBITDA | 0.56 | |||||
EV-to-Revenue | -1.4 | |||||
EV-to-Forward-Revenue | 0.01 | |||||
EV-to-FCF | 0.52 | |||||
Price-to-Net-Current-Asset-Value | 0.32 | |||||
Price-to-Net-Cash | 0.54 | |||||
Earnings Yield (Greenblatt) % | 181.82 | |||||
FCF Yield % | -562.49 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Arcadia Biosciences Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 5.26 | ||
EPS (TTM) (€) | -13.176 | ||
Beta | 0.82 | ||
Volatility % | 52.98 | ||
14-Day RSI | 42.08 | ||
14-Day ATR (€) | 0.062899 | ||
20-Day SMA (€) | 1.86 | ||
12-1 Month Momentum % | -66.37 | ||
52-Week Range (€) | 1.75 - 5.95 | ||
Shares Outstanding (Mil) | 1.36 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Arcadia Biosciences Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Arcadia Biosciences Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Arcadia Biosciences Inc Frequently Asked Questions
What is Arcadia Biosciences Inc(FRA:17D)'s stock price today?
When is next earnings date of Arcadia Biosciences Inc(FRA:17D)?
Does Arcadia Biosciences Inc(FRA:17D) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |